| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1099597930 |
| P356 | DOI | 10.1038/S41598-017-16085-Y |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/s41598-017-16085-y |
| P932 | PMC publication ID | 5727535 |
| P698 | PubMed publication ID | 29235457 |
| P50 | author | Di Yu | Q52976063 |
| Yanfang Cui | Q47155689 | ||
| P2093 | author name string | Hui Geng | |
| Jing Tang | |||
| Shan Xu | |||
| Dandan Song | |||
| Sheng Hu | |||
| Xianmin Zhu | |||
| Yanping Zhou | |||
| P2860 | cites work | Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management. Preface. | Q53113916 |
| Maintenance or Consolidation Therapy for Non--Small-Cell Lung Cancer: A Meta-Analysis Involving 5841 Subjects. | Q53618523 | ||
| MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer. | Q55057043 | ||
| Orthogonal projections to latent structures (O-PLS) | Q56435041 | ||
| Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Blood Plasma | Q58040357 | ||
| A serum nuclear magnetic resonance-based metabolomic signature of advanced metastatic human breast cancer | Q61780836 | ||
| [New guidelines to evaluate the response to treatment in solid tumors] | Q64112210 | ||
| Combined evaluation of Rad51 and ERCC1 expressions for sensitivity to platinum agents in non-small cell lung cancer | Q80119388 | ||
| Inhibition of heat shock protein 90 (HSP90) as a therapeutic strategy for the treatment of myeloma and other cancers | Q37827173 | ||
| The role of choline in prostate cancer. | Q38037833 | ||
| Metabolic phenotyping in clinical and surgical environments | Q38059779 | ||
| Co-clinical trials demonstrate superiority of crizotinib to chemotherapy in ALK-rearranged non-small cell lung cancer and predict strategies to overcome resistance | Q38194999 | ||
| Pharmacogenomics in lung cancer chemotherapy: a review of what the oncologist should know. | Q38256038 | ||
| P-glycoprotein and membrane roles in multidrug resistance. | Q38523606 | ||
| Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non-Small Cell Lung Cancer. | Q38848794 | ||
| Nivolumab and Pembrolizumab for Non-Small Cell Lung Cancer | Q38851210 | ||
| Potential markers of cisplatin treatment response unveiled by NMR metabolomics of human lung cells. | Q39094130 | ||
| Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer | Q41134662 | ||
| Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds | Q41589546 | ||
| Combined NMR and LC-DAD-MS analysis reveals comprehensive metabonomic variations for three phenotypic cultivars of Salvia Miltiorrhiza Bunge | Q43196501 | ||
| Applying biofluid 1H NMR-based metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative individuals | Q44359392 | ||
| Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
| First-line crizotinib versus chemotherapy in ALK-positive lung cancer | Q27853101 | ||
| Global cancer statistics, 2012 | Q27860501 | ||
| Cancer statistics, 2015 | Q27860576 | ||
| Cancer statistics, 2014 | Q27861018 | ||
| Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas: confirmation of the correlations with histologic subtypes and gene mutations | Q28307000 | ||
| Magnetic resonance spectroscopy detectable metabolomic fingerprint of response to antineoplastic treatment | Q28477468 | ||
| The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth | Q29547680 | ||
| ERCC1 isoform expression and DNA repair in non-small-cell lung cancer | Q30580553 | ||
| Combined NMR and LC-MS analysis reveals the metabonomic changes in Salvia miltiorrhiza Bunge induced by water depletion | Q33521569 | ||
| Comparison of squamous cell carcinoma and adenocarcinoma of the lung by metabolomic analysis of tissue-serum pairs. | Q33712528 | ||
| Chemotherapy-induced dynamic gene expression changes in vivo are prognostic in ovarian cancer | Q33750182 | ||
| DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy | Q34564091 | ||
| Choline metabolism in malignant transformation | Q35112040 | ||
| The role of docetaxel in the treatment of non-small cell lung cancer lung cancer: an update | Q36142491 | ||
| Three plasma metabolite signatures for diagnosing high altitude pulmonary edema | Q36150268 | ||
| Dysregulated lipid metabolism in cancer | Q36198689 | ||
| Lung cancer: Biology and treatment options | Q36328370 | ||
| First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial | Q36368641 | ||
| Temporal molecular and biological assessment of an erlotinib-resistant lung adenocarcinoma model reveals markers of tumor progression and treatment response | Q36407251 | ||
| Phosphatidylcholine and the CDP-choline cycle. | Q36581975 | ||
| Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment | Q36761890 | ||
| Tumor growth affects the metabonomic phenotypes of multiple mouse non-involved organs in an A549 lung cancer xenograft model. | Q37027394 | ||
| Early stage diagnosis of oral cancer using 1H NMR-based metabolomics | Q37109550 | ||
| Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. | Q37552177 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 17524 | |
| P577 | publication date | 2017-12-13 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Serum Metabolic Profile Alteration Reveals Response to Platinum-Based Combination Chemotherapy for Lung Cancer: Sensitive Patients Distinguished from Insensitive ones | |
| P478 | volume | 7 |
| Q92816460 | NMR-Based Metabolomics in Metal-Based Drug Research |
| Q92669550 | NMR-based metabolomics in real-time monitoring of treatment induced toxicity and cachexia in head and neck cancer: a method for early detection of high risk patients |
| Q64092243 | Stratification of cancer and diabetes based on circulating levels of formate and glucose |
Search more.